Minerva Neurosciences, Inc. Annual Operating Income (Loss) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Minerva Neurosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • Minerva Neurosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$4.52M, a 36.9% increase year-over-year.
  • Minerva Neurosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$21.8M, a 5.5% increase year-over-year.
  • Minerva Neurosciences, Inc. annual Operating Income (Loss) for 2024 was -$21.8M, a 5.5% increase from 2023.
  • Minerva Neurosciences, Inc. annual Operating Income (Loss) for 2023 was -$23.1M, a 8.37% increase from 2022.
  • Minerva Neurosciences, Inc. annual Operating Income (Loss) for 2022 was -$25.2M, a 44.4% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$21.8M +$1.27M +5.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$23.1M +$2.11M +8.37% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$25.2M +$20.1M +44.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$45.4M -$47.2M -2557% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $1.85M +$77.7M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$75.9M -$24.1M -46.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 -$51.7M -$10.6M -25.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$41.2M -$11M -36.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$30.2M -$4.08M -15.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 -$26.1M +$28.8M +52.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$54.9M -$51.7M -1628% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 -$3.17M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.